Report: Pharmaceutical Water System Validation Summary

This is a ready-to-use validation summary report that closes a pharmaceutical water system qualification. Unlike a generic system VSR, it is built around the shape unique to water: the engineering qualification confirms the system was built and operates as designed, and the real proof of performance is the three-phase PQ that runs a full year across seasonal feedwater variation. Replace every <<FILL: ...>> placeholder, attach the executed protocols and deviation records, and route it through document control and approval. A filled specimen follows. Verify each cited chapter and regulation against the current source. This is general guidance to adapt, not legal or regulatory advice.

Document control header

Field	Entry
Document title	Validation Summary Report for `<<FILL: SYSTEM NAME, e.g. WFI Loop, Building 3>>`
Document number	`<<FILL: VSR-ID>>`
Version	`<<FILL: version, e.g. 1.0>>`
Effective date	`<<FILL: effective date>>`
Supersedes	`<<FILL: prior version or "New">>`
Document owner	`<<FILL: role, e.g. Validation Lead>>`
Linked validation master plan entry	`<<FILL: VMP reference>>`
Grade(s) covered	Purified Water / Water for Injection / Pure Steam

1. Purpose

This report closes the validation of <<FILL: SYSTEM NAME>> and concludes on its fitness to generate, store, and distribute water meeting the required grade for its intended points of use. It summarizes the engineering qualification, the full three-phase performance qualification, the attributes achieved against their limits, deviations and their resolution, and the decision to release the system to routine use.

2. System description and scope

Item	Entry
Grade(s) generated	`<<FILL>>`
Generation technology	`<<FILL: e.g. RO + EDI, distillation>>`
Loop design	`<<FILL: hot 80-85 C continuous / ambient with periodic sanitization / ozonated cold>>`
Points of use in scope	`<<FILL: count and list, or reference the P&ID>>`
Sites / areas served	`<<FILL>>`
Explicitly out of scope	`<<FILL: e.g. a separate loop, a not-yet-connected point of use>>`

3. References

Document	Number	Title
User requirements specification	`<<FILL>>`	`<<FILL>>`
Dead-leg / biofilm risk assessment	`<<FILL>>`	`<<FILL>>`
IQ protocol	`<<FILL>>`	`<<FILL>>`
OQ protocol	`<<FILL>>`	`<<FILL>>`
Three-phase PQ protocol	`<<FILL>>`	`<<FILL>>`
Sampling and monitoring SOP	`<<FILL>>`	`<<FILL>>`
Alert/action level derivation worksheet(s)	`<<FILL>>`	`<<FILL>>`

4. Engineering qualification outcome (IQ/OQ)

Deliverable	Executed	Outcome	Deviations
Installation qualification	Yes/No	`<<FILL: Pass / Pass with deviations>>`	`<<FILL>>`
Operational qualification	Yes/No	`<<FILL>>`	`<<FILL>>`
Sanitization cycle development (temperature/ozone mapping)	Yes/No	`<<FILL>>`	`<<FILL>>`
Control system (PLC/SCADA) qualification	Yes/No	`<<FILL>>`	`<<FILL>>`

Narrative: <<FILL: confirm the system was installed per the approved design, operates within its defined ranges, and that sanitization reaches the mapped worst-case point at temperature/dose for the required hold time.>>

5. Three-phase performance qualification results

5.1 Phase 1 (intensive daily monitoring)

Item	Entry
Duration	`<<FILL: dates, typically 14-28 days>>`
Sampling	Every point of use, daily
Result	`<<FILL: all attributes within limits / exceptions and resolution>>`
Water released for product use during this phase	No

5.2 Phase 2 (confirmation under routine SOPs)

Item	Entry
Duration	`<<FILL: dates>>`
Sampling	Every point of use, daily, under the finalized routine SOPs
Result	`<<FILL>>`
Water released for product use at end of phase	`<<FILL: Yes/No and risk-basis rationale>>`

5.3 Phase 3 (one full year, seasonal coverage)

Item	Entry
Duration	`<<FILL: start date>>` to `<<FILL: end date, must span a full year>>`
Sampling	Rotating schedule, every point of use covered within each `<<FILL: week/cycle>>`
Seasons covered	`<<FILL: confirm all four seasons of feedwater variation were observed>>`
Result	`<<FILL>>`

6. Attributes achieved against limits

Attribute	Method	Limit / guidance	Result achieved	In control?
Conductivity	USP <645>	`<<FILL: per temperature table>>`	`<<FILL>>`	Yes/No
TOC	USP <643>	`<<FILL: e.g. not more than 500 ppb>>`	`<<FILL>>`	Yes/No
Microbial count	Membrane filtration / plate	`<<FILL: 100 CFU/mL PW or 10 CFU/100 mL WFI, compendial guidance>>`	`<<FILL>>`	Yes/No
Endotoxin (WFI only)	USP <85> LAL	Not more than 0.25 EU/mL	`<<FILL>>`	Yes/No

7. Alert and action levels established

Point of use	Alert level	Action level	Derivation reference
`<<FILL>>`	`<<FILL>>`	`<<FILL>>`	`<<FILL: worksheet number>>`
`<<FILL>>`	`<<FILL>>`	`<<FILL>>`	`<<FILL>>`

8. Deviations and resolution

Deviation #	Phase	Description	Root cause	Product impact	Resolution
`<<FILL>>`	`<<FILL>>`	`<<FILL>>`	`<<FILL>>`	`<<FILL>>`	`<<FILL>>`

State plainly: <<FILL: "All deviations were closed with no unresolved impact on the validated conclusion" or the specific residual concern carried forward.>>

9. Ongoing monitoring program

State the routine sampling frequency and the sanitization frequency confirmed adequate by the qualification, and reference the SOP that governs them going forward: <<FILL>>.

10. Residual risk and conclusion

<<FILL: state the residual risk accepted, if any, and conclude plainly whether the system is validated and fit for its intended use across the grade(s) and points of use in scope.>>

11. Release statement

<<FILL: SYSTEM NAME>> is declared validated for the generation, storage, and distribution of <<FILL: grade(s)>> at the points of use listed in section 2, effective <<FILL: date>>, subject to the ongoing monitoring program in section 9 and periodic requalification per <<FILL: SOP-ID>>.

12. Regulatory and compendial basis

USP General Chapter <1231>, Water for Pharmaceutical Purposes. USP <645> Water Conductivity; USP <643> Total Organic Carbon; USP <85> Bacterial Endotoxins Test. USP Purified Water and Water for Injection monographs. 21 CFR 211.48 (Plumbing) and 21 CFR Part 211 general facility expectations. EU GMP Annex 1 (2022 revision) where applicable. FDA, Guide to Inspections of High Purity Water Systems.

Confirm the current edition and clause numbers of each reference before issue.

13. Revision history

Version	Date	Author	Summary of change
`<<FILL: 1.0>>`	`<<FILL: date>>`	`<<FILL: author>>`	Initial issue.

14. Approvals

Role	Name	Signature	Date
Author (Validation)	`<<FILL>>`
QC Microbiology	`<<FILL>>`
Utilities / Engineering	`<<FILL>>`
Approver (QA)	`<<FILL>>`

Filled specimen (excerpt)

Item	Entry
System	WFI Loop, Building 3, continuously hot (82 C)
Phase 3 duration	03-Mar-2025 to 02-Mar-2026, all four seasons observed
Conductivity	In control at all points, Stage 1 pass throughout
TOC	In control, range 38-210 ppb against a 500 ppb limit
Microbial	In control; one alert-level exceedance at POU-07 in August (result 9 CFU/100 mL, alert 8), trended, no action-level breach, resolved as isolated
Endotoxin	In control, all results below 0.1 EU/mL
Conclusion	System declared validated for WFI generation, storage, and distribution at the 11 qualified points of use, effective 15-Mar-2026

The single alert-level exceedance is reported rather than omitted, and its disposition (trended, no action breach, isolated) is exactly the kind of evidence an inspector expects a monitoring program to produce and a VSR to summarize honestly rather than presenting a record with zero events as if that were normal for a full year of operation.

Common inspection findings this report prevents

A VSR that declares the system validated after a shortened or skipped Phase 3, with no evidence of performance across seasonal feedwater variation.
Attributes reported as “all passed” with no reconciliation against the underlying sampling and monitoring log.
Alert-level exceedances omitted from the summary because none breached the action level, hiding the trend data an inspector will ask to see.
No traceable link between the alert/action levels used during Phase 3 and the worksheet that derived them.
A release statement with no reference to the ongoing monitoring program that keeps the validated state current.

How to adapt this report

Set the document header, system description, and grade(s) covered.
Attach or reference every protocol and log the report summarizes; do not restate their content, point to it.
Report Phase 3 results honestly, including alert-level exceedances and how they were dispositioned, not only action-level breaches.
Tie the alert/action levels in section 7 to their derivation worksheet by reference number.
State the residual risk plainly in section 10, even when it is “none identified.”
Confirm every reference in section 12 against the current published version before issue.